Sedative, hypnotic or anxiolytic dependence with withdrawal, uncomplicated
ICD-10 F13.230 is a billable code used to indicate a diagnosis of sedative, hypnotic or anxiolytic dependence with withdrawal, uncomplicated.
F13.230 refers to a condition characterized by the dependence on sedative, hypnotic, or anxiolytic substances, accompanied by withdrawal symptoms that are uncomplicated. This diagnosis is typically applied when an individual has developed a psychological and/or physical dependence on these substances, leading to a range of withdrawal symptoms upon cessation. Common sedatives include benzodiazepines, barbiturates, and certain sleep medications. Withdrawal symptoms can manifest as anxiety, insomnia, tremors, and in severe cases, seizures. The uncomplicated nature of this diagnosis indicates that the withdrawal symptoms are not severe enough to require hospitalization or intensive medical intervention. Treatment often involves a gradual tapering of the substance, supportive care, and possibly the use of alternative medications to manage withdrawal symptoms. Understanding the nuances of this diagnosis is crucial for effective treatment planning and accurate coding.
Detailed history of substance use, withdrawal symptoms, and treatment plans.
Patients presenting with anxiety and insomnia after cessation of benzodiazepines.
Ensure documentation reflects the severity of withdrawal and any co-occurring mental health issues.
Comprehensive psychiatric evaluations and treatment progress notes.
Patients with a history of anxiety disorders who have developed dependence on anxiolytics.
Document any psychiatric comorbidities that may complicate treatment.
Used in conjunction with F13.230 when addressing substance use disorders.
Document the counseling session details and patient progress.
Addiction specialists may need to provide additional context for the counseling provided.
Common withdrawal symptoms include anxiety, insomnia, tremors, sweating, and in severe cases, seizures. The severity of symptoms can vary based on the substance and duration of use.
